Cell-Free Supernatant of Bacillus thuringiensis Displays Anti-Biofilm Activity Against Staphylococcus aureus

Appl Biochem Biotechnol. 2023 Sep;195(9):5379-5393. doi: 10.1007/s12010-022-03971-z. Epub 2022 May 20.

Abstract

Staphylococcus aureus is an important bacterial pathogen responsible for biofilm formation in medical devices. Due to the increasing antibiotic resistance of S. aureus, it is necessary to search for new anti-biofilm agents. In this study, the cell-free supernatant of Bacillus thuringiensis inhibited biofilm formation up to 93% and dispersed biofilms up to 83% without affecting the growth of S. aureus. The ethyl acetate extract of B. thuringiensis cell-free supernatant exhibited a dose-dependent anti-biofilm activity against S. aureus with the biofilm inhibition concentration ranging from 8 to 64 µg/mL. Scanning electron microscopy revealed that the cell-free supernatant extract of B. thuringiensis resulted in a significant reduction in S. aureus biofilms. The ethyl acetate extract of cell-free supernatant of B. thuringiensis was found to contain various compounds with structural similarity to known anti-biofilm compounds. In particular, squalene, cinnamic acid derivatives, and eicosapentaene seem to act synergistically against S. aureus biofilms. Hence, B. thuringiensis cell-free supernatant proved to be effective against S. aureus biofilms. The results clearly show the potential of natural molecules produced by B. thuringiensis as alternative therapies with anti-biofilm activity instead of bactericidal properties.

Keywords: Anti-biofilm; Bacillus; Cell-free extract; Squalene; Staphylococcus aureus.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacillus thuringiensis*
  • Biofilms
  • Humans
  • Microbial Sensitivity Tests
  • Staphylococcal Infections* / microbiology
  • Staphylococcus aureus

Substances

  • ethyl acetate
  • Anti-Bacterial Agents